Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Liquid Biopsy in Melanoma: Significance in Diagnostics, Prediction and Treatment Monitoring. | Int J Mol Sci | 2021 | 34575876 | PubTator, text mining | PubMed |
| Interrogating Epigenome toward Personalized Approach in Cutaneous Melanoma. | J Pers Med | 2021 | 34575678 | PubTator, text mining | PubMed |
| Evolution of CD8+ T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer. | Cells | 2021 | 34572028 | PubTator, text mining | PubMed |
| Immune escape mechanisms and immunotherapy of urothelial bladder cancer. | J Clin Transl Res | 2021 | 34541363 | PubTator, text mining | PubMed |
| Survival benefit of immune checkpoint inhibitor monotherapy in patients with non-small cell lung cancer recurrence after completely pulmonary resection. | Ann Transl Med | 2021 | 34532362 | PubTator, text mining | PubMed |
| A Preliminary Study of the Complement Component 1q Levels in Predicting the Efficacy of Combined Immunotherapy in Patients with Lung Cancer. | Cancer Manag Res | 2021 | 34531687 | PubTator, text mining | PubMed |
| The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies. | Hemasphere | 2021 | 34522844 | PubTator, text mining | PubMed |
| Long non-coding RNA FGD5-AS1 contributes to cisplatin resistance in hepatocellular carcinoma via sponging microRNA-153-3p by upregulating Twinfilin Actin Binding Protein 1 (TWF1). | Bioengineered | 2021 | 34519634 | PubTator, text mining | PubMed |
| Identification of Immune Cell Infiltration Landscape and Their Prognostic Significance in Uveal Melanoma. | Front Cell Dev Biol | 2021 | 34513843 | PubTator, text mining | PubMed |
| Targeting the Microenvironment in Esophageal Cancer. | Front Cell Dev Biol | 2021 | 34513829 | PubTator, text mining | PubMed |
| Therapeutic cancer vaccines revamping: technology advancements and pitfalls. | Ann Oncol | 2021 | 34500046 | PubTator, text mining | PubMed |
| Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages. | BMC Cancer | 2021 | 34496797 | PubTator, text mining | PubMed |
Dendritic cells matured with recombinant human sperm associated antigen 9 (rhSPAG9) induce CD4+, CD8+ T cells and activate NK cells: a potential candidate molecule for immunotherapy in cervical cancer. | Cancer Cell Int | 2021 | 34493268 | PubTator, text mining | PubMed |
| Association of Circulating, Inflammatory-Response Exosomal mRNAs With Acute Myocardial Infarction. | Front Cardiovasc Med | 2021 | 34490374 | PubTator, text mining | PubMed |
| Current Insights and Advancements in Head and Neck Cancer: Emerging Biomarkers and Therapeutics with Cues from Single Cell and 3D Model Omics Profiling. | Front Oncol | 2021 | 34490084 | PubTator, text mining | PubMed |
| Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy. | J Immunother Cancer | 2021 | 34479921 | PubTator, text mining | PubMed |
| Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells. | J Cancer | 2021 | 34475991 | PubTator, text mining | PubMed |
| Advanced Nanotechnologies for Extracellular Vesicle-Based Liquid Biopsy. | Adv Sci (Weinh) | 2021 | 34463056 | PubTator, text mining | PubMed |
| Transcriptional overlap links DNA hypomethylation with DNA hypermethylation at adjacent promoters in cancer. | Sci Rep | 2021 | 34462486 | PubTator, text mining | PubMed |
| The expression of multiple cancer/testis antigens can potentially be used to detect circulating disease and clonal evolution in the peripheral blood of multiple myeloma patients. | Blood Res | 2021 | 34462402 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=38